- Transplant program directors, administrators, coordinators, compliance and quality officers, and clinical support staff
- OPO CEOs, medical directors, procurement directors and coordinators, compliance and quality officers
- Lab directors and general supervisors
- Primary data coordinators
- Patient safety contacts
- Member representatives and alternate representatives
Implementation date: March 1, 2021
Effective March 1, a number of Organ Procurement and Transplantation Network policies will be implemented to align with the 2020 U.S. Public Health Service Guideline for assessing solid organ donors and monitoring transplant recipients for HIV, hepatitis B (HBV), and hepatitis C (HCV). Please see the January pre-implementation notice to view policy, implementation and other changes, as well as actions members will need to take.
New educational resources are available, and a webinar will be held on Wednesday, February 24 to help you prepare for the updated policies.
February 24 Webinar
An informational webinar will be held Wednesday, February 24, from 4 to 5 p.m. EST, to guide participants through the changes and address common questions already received from members about implementation. Attendees will have the chance to ask any additional questions at the end. Registration is available here. The webinar will be recorded and made available for later review.
Education and resources
- A frequently asked questions document addresses common topics relating to the new requirements. This document will be updated as needed based on additional feedback.
- A preview is available of changes to the OPTN Evaluation Plan that will result from the newly added and updated policies.
- Two educational offerings are available on UNOS Connect:
- SFT127: PHS Guidelines in OPTN Policy
- SFT128: Talking About Risk Criteria for Disease Transmission
- OPTN policy notice: Align OPTN Policy with US Public Health Service Guideline, 2020
- 2020 PHS Guideline
- Crosswalk between 2013 and 2020 PHS Guideline and OPTN policies